Original Research

Accepted on 21 Nov 2024

Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine clinical practice

in Multiple Sclerosis and Neuroimmunology

Edgar Carnero Contentti
Juan Ignacio Rojas
Ricardo Alonso
Michael Yeaman
Brian Weinshenker

Frontiers in Immunology

doi 10.3389/fimmu.2024.1515481

Original Research

Accepted on 20 Nov 2024

Review of Clinical and Imaging Findings in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy to Aid in Early Diagnosis

in Multiple Sclerosis and Neuroimmunology

Xiaomeng Li
Jiacun Li
Han Xu
Xiaohui Liu
Meilin Li
Jingzhen He
Jianjun Xiu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466847

Original Research

Published on 20 Nov 2024

The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI

in Multiple Sclerosis and Neuroimmunology

Rida Rehman
Albrecht Froehlich
Florian olde Heuvel
Lobna Elsayed
Tobias Boeckers
Markus Huber-Lang
Cristina Morganti-Kossmann
Francesco Roselli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443940

117 views

Original Research

Published on 19 Nov 2024

Stimulation of microneedles alleviates pathology of Parkinson’s disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain

in Multiple Sclerosis and Neuroimmunology

Jin Hee Kim
Yujin Choi
Jin Se Kim
Hanbyeol Lee
In Gyoung Ju
Na Young Yoo
Sookie La
Do Hyeon Jeong
Changsu Na
Hi-Joon Park

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454102

172 views

Review

Accepted on 18 Nov 2024

Temporal changes of spinal microglia in murine models of neuropathic pain: a scoping review

in Multiple Sclerosis and Neuroimmunology

Simran Dhir
Hannah Derue
Alfredo Ribeiro-da-Silva

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460072

Case Report

Accepted on 18 Nov 2024

Chronic inflammatory demyelinating polyradiculoneuropathy with severe central nervous system demyelination: a clinicopathological study

in Multiple Sclerosis and Neuroimmunology

Goichi Beck
Rika Yamashita
Makiko Kawai
Ryohei Yamamura
Tatsusada Okuno
Misa Matsui
Keiko Toyooka
Eiichi Morii
Hideki Mochizuki
Shigeo Murayama

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477615

Original Research

Accepted on 18 Nov 2024

Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis

in Multiple Sclerosis and Neuroimmunology

Sarah Jesse
Marie Riemann
Hauke Schneider
Marius Ringelstein
Nico Melzer
Niklas Vogel
Lena Kristina Pfeffer
Manuel Friese
Kurt-Wolfram Sühs
Dominica Hudasch

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500904

Case Report

Published on 18 Nov 2024

Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review

in Multiple Sclerosis and Neuroimmunology

Jia Wang
Haotao Zheng
Jia Wei
Jiaping Wu
Ziyang Feng
Xueqin Chen
Yangsicheng Liu
Wenxin Qin
Xiude Qin
Fanxin Kong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456822

184 views

Original Research

Accepted on 14 Nov 2024

Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response

in Multiple Sclerosis and Neuroimmunology

Zuzana Jiraskova Zakostelska
Michal Kraus
Stepan Coufal
Petra Procházková
Zaneta Slavickova
Tomas Thon
Tomas Hrncir
Jakub Kreisinger
Klara Kostovcikova
Pavlina Kleinova

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475126

Original Research

Published on 14 Nov 2024

Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation

in Multiple Sclerosis and Neuroimmunology

Xinzhan Jiang
Hongyu Zhang
Yongtao Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442694

280 views

Original Research

Accepted on 13 Nov 2024

Research hotspots and trends for Duchenne muscular dystrophy: A machine learning bibliometric analysis from 2004 to 2023

in Multiple Sclerosis and Neuroimmunology

Pingping Fang
Jingzhe Han
Di AN
Yi Bu
Guang Ji
Mingjuan Liu
Jinliang Deng
Moran Guo
Xu Han
Hongran Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429609

Original Research

Published on 12 Nov 2024

Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Fernando Rodríguez-Jorge
José Ignacio Fernández-Velasco
Noelia Villarrubia
Julia Gracia-Gil
Eva Fernández
Virginia Meca-Lallana
Carolina Díaz-Pérez
Susana Sainz de la Maza
Eva María Pacheco
Ana Quiroga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480676

378 views

Original Research

Accepted on 08 Nov 2024

In-depth analysis of serum antibodies against Epstein-Barr virus (EBV) lifecycle proteins and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Nicole Vasilenko
Maria P. Tieck
Tanja Michel
Sonja Schembecker
Patricia Schwarz
Christoph Ruschil
Sven Poli
Ulf Ziemann
Antje Giede-Jeppe
Gisela Gabernet

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487523

115 views

Case Report

Published on 07 Nov 2024

Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis

in Multiple Sclerosis and Neuroimmunology

Min Deng
Fei Zeng
Zhaohong Kong
Tao Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456840

172 views

Case Report

Published on 06 Nov 2024

Case report: Infectious mononucleosis with bilateral retinal haemorrhages under myelin oligodendrocyte glycoprotein antibody-associated disease

in Multiple Sclerosis and Neuroimmunology

Yuyu Li
Mingming Sun
Shihui Wei
Quangang Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480134

177 views

Review

Accepted on 05 Nov 2024

Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression

in Multiple Sclerosis and Neuroimmunology

Hanne Coenen
Veerle Somers
Judith Fraussen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495801

Navigation group

Articles

Application and interpretation of core elements of the 2015 NMOSD diagnostic criteria in routine clinical practice

Review of Clinical and Imaging Findings in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy to Aid in Early Diagnosis

The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI

Stimulation of microneedles alleviates pathology of Parkinson’s disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain

Temporal changes of spinal microglia in murine models of neuropathic pain: a scoping review

Chronic inflammatory demyelinating polyradiculoneuropathy with severe central nervous system demyelination: a clinicopathological study

Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis

Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review

Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response

Global perspectives on the contribution of B cells to multiple sclerosis: an in-depth examination and evaluation

Research hotspots and trends for Duchenne muscular dystrophy: A machine learning bibliometric analysis from 2004 to 2023

Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

In-depth analysis of serum antibodies against Epstein-Barr virus (EBV) lifecycle proteins and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis

Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis

Case report: Infectious mononucleosis with bilateral retinal haemorrhages under myelin oligodendrocyte glycoprotein antibody-associated disease

Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression